Home
Bios Fund II NT, 10% Owner: Lantern Pharma LTRN Sell · Filed 25/06/13
Trade details
- Type
- Insider sale
- Amount
- $38,065.71
- Shares · price
- 12,319 sh · $3.09 a share
- Held after
- 323,335 sh
- Stock
- Lantern Pharma LTRN
- Person
- Bios Fund II NT10% Owner
- Trade date
- 25/06/13
- Filed
- 25/06/13
- Days to filing
- 0 days
Sold 3.7% of holdings
- Share of holding sold
- 3.7%
Lantern Pharma trades, last 26 weeks
What else happened in Lantern Pharma around then
Filed or reported within 30 days of the trade day · 25/05/14~25/07/13Bios Fund II NT's recent trades
- Bios Fund II NT
BuyActuate Therapeutics
BuyActuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
- Bios Fund II NT
SellLantern Pharma
SellLantern Pharma
LTRN
$43.9K
14,218 sh
$43.9K
Filed 25/06/13
Traded 25/06/13
- Bios Fund II NT
SellLantern Pharma
SellLantern Pharma
LTRN
$22.3K
7,206 sh
$22.3K
Filed 25/06/13
Traded 25/06/13
- Bios Fund II NT
SellLantern Pharma
SellLantern Pharma
LTRN
$13.5K
4,354 sh
$13.5K
Filed 25/06/13
Traded 25/06/13
- Bios Fund II NT
SellLantern Pharma
SellLantern Pharma
LTRN
$5,880
1,903 sh
$5,880
Filed 25/06/13
Traded 25/06/13
